Psychotropic combination in schizophrenia View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2005-12

AUTHORS

E. Acquaviva, I. Gasquet, B. Falissard

ABSTRACT

OBJECTIVE: To study adjunctive medications used with antipsychotic agents in schizophrenia via comparisons of antidepressant, anxiolytic and antiparkinsonian co-prescribing. METHOD: In the context of a national naturalistic prospective observational study, a database containing all the prescriptions from 100 French psychiatrists during the year 2002 was analysed. The inclusion criteria were a diagnosis of schizophrenia or schizoaffective disorder and age over 18. A log-linear model and generalised linear mixed models were used. RESULTS: In all 5,257 prescriptions for 922 patients were analysed. The proportion of patients who were prescribed an antiparkinsonian drug was 32.9%. Amisulpride, haloperidol, phenothiazines with a sedative action and depot typical antipsychotics proved more likely to be prescribed with antiparkinsonians. The frequency of antidepressant and anxiolytic prescriptions was 51.2% and 52.3%, respectively. Associations between atypical antipsychotics (except clozapine) and antidepressants were positive while associations between typical antipsychotics and antidepressants were not. There were no differences among antipsychotics for the prescription of anxiolytics. CONCLUSIONS: Atypical antipsychotics can be expected to be less likely associated with antiparkinsonians. This result is indeed found for olanzapine, clozapine and to a limited extent for risperidone. Furthermore, a trend towards a positive association between atypical antipsychotics and antidepressants appears. In view of the antidepressive action of certain atypical antipsychotics, this result is surprising. The increase in the prescriptions of anxiolytics concerns all types of antipsychotics. In view of the increase in associated medications in schizophrenia and the difficulty of estimating it in randomised trials, this study underlines the contribution of naturalistic studies on this score. More... »

PAGES

855-861

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s00228-005-0034-6

DOI

http://dx.doi.org/10.1007/s00228-005-0034-6

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1017392083

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/16283277


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Anti-Anxiety Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antiparkinson Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antipsychotic Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Databases, Factual", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Therapy, Combination", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "France", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Linear Models", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Pharmacoepidemiology", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Schizophrenia", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "H\u00f4pital Cochin", 
          "id": "https://www.grid.ac/institutes/grid.411784.f", 
          "name": [
            "Inserm U669 PSIGIAM (Paris Sud Innovation Group In Adolescent Mental health Methodology), Cochin Hospital, 97 boulevard de Port Royal, 75679, Paris cedex 14, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Acquaviva", 
        "givenName": "E.", 
        "id": "sg:person.01303707125.52", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01303707125.52"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "H\u00f4pital Cochin", 
          "id": "https://www.grid.ac/institutes/grid.411784.f", 
          "name": [
            "Inserm U669 PSIGIAM (Paris Sud Innovation Group In Adolescent Mental health Methodology), Cochin Hospital, 97 boulevard de Port Royal, 75679, Paris cedex 14, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Gasquet", 
        "givenName": "I.", 
        "id": "sg:person.01305100737.31", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01305100737.31"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "H\u00f4pital Cochin", 
          "id": "https://www.grid.ac/institutes/grid.411784.f", 
          "name": [
            "Inserm U669 PSIGIAM (Paris Sud Innovation Group In Adolescent Mental health Methodology), Cochin Hospital, 97 boulevard de Port Royal, 75679, Paris cedex 14, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Falissard", 
        "givenName": "B.", 
        "id": "sg:person.0726576642.85", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0726576642.85"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/s00228-004-0803-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000276917", 
          "https://doi.org/10.1007/s00228-004-0803-7"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0920-9964(01)00309-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001155253"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0278-5846(01)00279-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001219320"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/14651858.cd002305", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009984671"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1046/j.1365-2125.2000.00108.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1012089803"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0750-7658(98)80017-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1012456994"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1440-1819.1997.tb03204.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024540211"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1001/archpsyc.60.6.553", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027426853"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1034/j.1600-0447.2002.00242.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032115125"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0924-9338(00)00222-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1040498665"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0924-977x(02)00031-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048794082"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1034/j.1399-5618.2000.020307.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049226594"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(03)13306-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050414744"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/oxfordjournals.schbul.a006928", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051418549"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1176/ajp.144.6.778", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1063477512"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1176/ajp.148.6.714", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1063480714"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1176/ajp.152.3.473-a", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1063483712"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1176/ajp.152.7.1038", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1063483905"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1176/appi.ajp.159.6.1035", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1063494678"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.4088/jcp.v63n1211", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1072208337"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1074477804", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1075039701", 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2005-12", 
    "datePublishedReg": "2005-12-01", 
    "description": "OBJECTIVE: To study adjunctive medications used with antipsychotic agents in schizophrenia via comparisons of antidepressant, anxiolytic and antiparkinsonian co-prescribing.\nMETHOD: In the context of a national naturalistic prospective observational study, a database containing all the prescriptions from 100 French psychiatrists during the year 2002 was analysed. The inclusion criteria were a diagnosis of schizophrenia or schizoaffective disorder and age over 18. A log-linear model and generalised linear mixed models were used.\nRESULTS: In all 5,257 prescriptions for 922 patients were analysed. The proportion of patients who were prescribed an antiparkinsonian drug was 32.9%. Amisulpride, haloperidol, phenothiazines with a sedative action and depot typical antipsychotics proved more likely to be prescribed with antiparkinsonians. The frequency of antidepressant and anxiolytic prescriptions was 51.2% and 52.3%, respectively. Associations between atypical antipsychotics (except clozapine) and antidepressants were positive while associations between typical antipsychotics and antidepressants were not. There were no differences among antipsychotics for the prescription of anxiolytics.\nCONCLUSIONS: Atypical antipsychotics can be expected to be less likely associated with antiparkinsonians. This result is indeed found for olanzapine, clozapine and to a limited extent for risperidone. Furthermore, a trend towards a positive association between atypical antipsychotics and antidepressants appears. In view of the antidepressive action of certain atypical antipsychotics, this result is surprising. The increase in the prescriptions of anxiolytics concerns all types of antipsychotics. In view of the increase in associated medications in schizophrenia and the difficulty of estimating it in randomised trials, this study underlines the contribution of naturalistic studies on this score.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s00228-005-0034-6", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1054337", 
        "issn": [
          "0031-6970", 
          "1432-1041"
        ], 
        "name": "European Journal of Clinical Pharmacology", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "11", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "61"
      }
    ], 
    "name": "Psychotropic combination in schizophrenia", 
    "pagination": "855-861", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "52dcc75fc47a6688b7c8eb8fc879501fa5b8b6e7fdc4d4eb8023f43c8f3a1148"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "16283277"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "1256165"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s00228-005-0034-6"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1017392083"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s00228-005-0034-6", 
      "https://app.dimensions.ai/details/publication/pub.1017392083"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T12:24", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000362_0000000362/records_87097_00000000.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1007%2Fs00228-005-0034-6"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00228-005-0034-6'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00228-005-0034-6'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00228-005-0034-6'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00228-005-0034-6'


 

This table displays all metadata directly associated to this object as RDF triples.

204 TRIPLES      21 PREDICATES      65 URIs      35 LITERALS      23 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s00228-005-0034-6 schema:about N053bbe5a26964e188609b3d7d15340e1
2 N22a8eb9ec8e446ada46affd4881ab895
3 N2b8b751790964e5589f462e761799221
4 N2f54574f2f12427188e40c4bb92ff3f2
5 N3b29bc28fb7b4589a194b96476fb9041
6 N438218e371bd40718529f6b4e71bee4f
7 N585a7ed2bfd54e1eb69f0b005f13e8aa
8 N91f76cc100c943cf9cd055b16789ae65
9 Na18ff4fd3f034e7287977d58471be928
10 Na1baa58560034eeeaee51a6358439f50
11 Nb086db4892e149c2b619a66dd199c8d4
12 Nb58e4775c1984c228f26a6ca5f36e218
13 Ncedb6761f3394d57895213a9062e3217
14 Nd5162e64b36a4653ab610acf6ee1e17e
15 anzsrc-for:11
16 anzsrc-for:1103
17 schema:author N3e198061f52a49da9c5e30cb40460cca
18 schema:citation sg:pub.10.1007/s00228-004-0803-7
19 https://app.dimensions.ai/details/publication/pub.1074477804
20 https://app.dimensions.ai/details/publication/pub.1075039701
21 https://doi.org/10.1001/archpsyc.60.6.553
22 https://doi.org/10.1002/14651858.cd002305
23 https://doi.org/10.1016/s0140-6736(03)13306-5
24 https://doi.org/10.1016/s0278-5846(01)00279-2
25 https://doi.org/10.1016/s0750-7658(98)80017-8
26 https://doi.org/10.1016/s0920-9964(01)00309-7
27 https://doi.org/10.1016/s0924-9338(00)00222-4
28 https://doi.org/10.1016/s0924-977x(02)00031-7
29 https://doi.org/10.1034/j.1399-5618.2000.020307.x
30 https://doi.org/10.1034/j.1600-0447.2002.00242.x
31 https://doi.org/10.1046/j.1365-2125.2000.00108.x
32 https://doi.org/10.1093/oxfordjournals.schbul.a006928
33 https://doi.org/10.1111/j.1440-1819.1997.tb03204.x
34 https://doi.org/10.1176/ajp.144.6.778
35 https://doi.org/10.1176/ajp.148.6.714
36 https://doi.org/10.1176/ajp.152.3.473-a
37 https://doi.org/10.1176/ajp.152.7.1038
38 https://doi.org/10.1176/appi.ajp.159.6.1035
39 https://doi.org/10.4088/jcp.v63n1211
40 schema:datePublished 2005-12
41 schema:datePublishedReg 2005-12-01
42 schema:description OBJECTIVE: To study adjunctive medications used with antipsychotic agents in schizophrenia via comparisons of antidepressant, anxiolytic and antiparkinsonian co-prescribing. METHOD: In the context of a national naturalistic prospective observational study, a database containing all the prescriptions from 100 French psychiatrists during the year 2002 was analysed. The inclusion criteria were a diagnosis of schizophrenia or schizoaffective disorder and age over 18. A log-linear model and generalised linear mixed models were used. RESULTS: In all 5,257 prescriptions for 922 patients were analysed. The proportion of patients who were prescribed an antiparkinsonian drug was 32.9%. Amisulpride, haloperidol, phenothiazines with a sedative action and depot typical antipsychotics proved more likely to be prescribed with antiparkinsonians. The frequency of antidepressant and anxiolytic prescriptions was 51.2% and 52.3%, respectively. Associations between atypical antipsychotics (except clozapine) and antidepressants were positive while associations between typical antipsychotics and antidepressants were not. There were no differences among antipsychotics for the prescription of anxiolytics. CONCLUSIONS: Atypical antipsychotics can be expected to be less likely associated with antiparkinsonians. This result is indeed found for olanzapine, clozapine and to a limited extent for risperidone. Furthermore, a trend towards a positive association between atypical antipsychotics and antidepressants appears. In view of the antidepressive action of certain atypical antipsychotics, this result is surprising. The increase in the prescriptions of anxiolytics concerns all types of antipsychotics. In view of the increase in associated medications in schizophrenia and the difficulty of estimating it in randomised trials, this study underlines the contribution of naturalistic studies on this score.
43 schema:genre research_article
44 schema:inLanguage en
45 schema:isAccessibleForFree false
46 schema:isPartOf N28b1915fe7a747258ca57590908af893
47 Ncc55de7ba9184683801c1dfc5c3ece33
48 sg:journal.1054337
49 schema:name Psychotropic combination in schizophrenia
50 schema:pagination 855-861
51 schema:productId N34c72f950e2e40b694fdd2c34226c928
52 Na1a8069910e84505b2feed8bb9c50856
53 Naf8cff1745c74bdfbcdbd7e920399eda
54 Nd7b9116db6ec4bdc819b775a4433c07f
55 Nff0003d933f44473bd3c4e6b68663d7a
56 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017392083
57 https://doi.org/10.1007/s00228-005-0034-6
58 schema:sdDatePublished 2019-04-11T12:24
59 schema:sdLicense https://scigraph.springernature.com/explorer/license/
60 schema:sdPublisher N365190a57a904ddf919b0ba1b176d9e8
61 schema:url http://link.springer.com/10.1007%2Fs00228-005-0034-6
62 sgo:license sg:explorer/license/
63 sgo:sdDataset articles
64 rdf:type schema:ScholarlyArticle
65 N053bbe5a26964e188609b3d7d15340e1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
66 schema:name Antipsychotic Agents
67 rdf:type schema:DefinedTerm
68 N22a8eb9ec8e446ada46affd4881ab895 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
69 schema:name Male
70 rdf:type schema:DefinedTerm
71 N239919242d8a4cc7b6c56b647e7d8c68 rdf:first sg:person.0726576642.85
72 rdf:rest rdf:nil
73 N28b1915fe7a747258ca57590908af893 schema:issueNumber 11
74 rdf:type schema:PublicationIssue
75 N2b8b751790964e5589f462e761799221 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
76 schema:name Female
77 rdf:type schema:DefinedTerm
78 N2f54574f2f12427188e40c4bb92ff3f2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
79 schema:name Schizophrenia
80 rdf:type schema:DefinedTerm
81 N34c72f950e2e40b694fdd2c34226c928 schema:name readcube_id
82 schema:value 52dcc75fc47a6688b7c8eb8fc879501fa5b8b6e7fdc4d4eb8023f43c8f3a1148
83 rdf:type schema:PropertyValue
84 N365190a57a904ddf919b0ba1b176d9e8 schema:name Springer Nature - SN SciGraph project
85 rdf:type schema:Organization
86 N3b29bc28fb7b4589a194b96476fb9041 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
87 schema:name Anti-Anxiety Agents
88 rdf:type schema:DefinedTerm
89 N3e198061f52a49da9c5e30cb40460cca rdf:first sg:person.01303707125.52
90 rdf:rest N7873af84b660465dbc616d1d82f42dcf
91 N438218e371bd40718529f6b4e71bee4f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
92 schema:name Adult
93 rdf:type schema:DefinedTerm
94 N585a7ed2bfd54e1eb69f0b005f13e8aa schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
95 schema:name France
96 rdf:type schema:DefinedTerm
97 N7873af84b660465dbc616d1d82f42dcf rdf:first sg:person.01305100737.31
98 rdf:rest N239919242d8a4cc7b6c56b647e7d8c68
99 N91f76cc100c943cf9cd055b16789ae65 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
100 schema:name Pharmacoepidemiology
101 rdf:type schema:DefinedTerm
102 Na18ff4fd3f034e7287977d58471be928 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
103 schema:name Antiparkinson Agents
104 rdf:type schema:DefinedTerm
105 Na1a8069910e84505b2feed8bb9c50856 schema:name dimensions_id
106 schema:value pub.1017392083
107 rdf:type schema:PropertyValue
108 Na1baa58560034eeeaee51a6358439f50 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
109 schema:name Databases, Factual
110 rdf:type schema:DefinedTerm
111 Naf8cff1745c74bdfbcdbd7e920399eda schema:name doi
112 schema:value 10.1007/s00228-005-0034-6
113 rdf:type schema:PropertyValue
114 Nb086db4892e149c2b619a66dd199c8d4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
115 schema:name Drug Therapy, Combination
116 rdf:type schema:DefinedTerm
117 Nb58e4775c1984c228f26a6ca5f36e218 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
118 schema:name Middle Aged
119 rdf:type schema:DefinedTerm
120 Ncc55de7ba9184683801c1dfc5c3ece33 schema:volumeNumber 61
121 rdf:type schema:PublicationVolume
122 Ncedb6761f3394d57895213a9062e3217 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
123 schema:name Humans
124 rdf:type schema:DefinedTerm
125 Nd5162e64b36a4653ab610acf6ee1e17e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
126 schema:name Linear Models
127 rdf:type schema:DefinedTerm
128 Nd7b9116db6ec4bdc819b775a4433c07f schema:name nlm_unique_id
129 schema:value 1256165
130 rdf:type schema:PropertyValue
131 Nff0003d933f44473bd3c4e6b68663d7a schema:name pubmed_id
132 schema:value 16283277
133 rdf:type schema:PropertyValue
134 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
135 schema:name Medical and Health Sciences
136 rdf:type schema:DefinedTerm
137 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
138 schema:name Clinical Sciences
139 rdf:type schema:DefinedTerm
140 sg:journal.1054337 schema:issn 0031-6970
141 1432-1041
142 schema:name European Journal of Clinical Pharmacology
143 rdf:type schema:Periodical
144 sg:person.01303707125.52 schema:affiliation https://www.grid.ac/institutes/grid.411784.f
145 schema:familyName Acquaviva
146 schema:givenName E.
147 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01303707125.52
148 rdf:type schema:Person
149 sg:person.01305100737.31 schema:affiliation https://www.grid.ac/institutes/grid.411784.f
150 schema:familyName Gasquet
151 schema:givenName I.
152 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01305100737.31
153 rdf:type schema:Person
154 sg:person.0726576642.85 schema:affiliation https://www.grid.ac/institutes/grid.411784.f
155 schema:familyName Falissard
156 schema:givenName B.
157 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0726576642.85
158 rdf:type schema:Person
159 sg:pub.10.1007/s00228-004-0803-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000276917
160 https://doi.org/10.1007/s00228-004-0803-7
161 rdf:type schema:CreativeWork
162 https://app.dimensions.ai/details/publication/pub.1074477804 schema:CreativeWork
163 https://app.dimensions.ai/details/publication/pub.1075039701 schema:CreativeWork
164 https://doi.org/10.1001/archpsyc.60.6.553 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027426853
165 rdf:type schema:CreativeWork
166 https://doi.org/10.1002/14651858.cd002305 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009984671
167 rdf:type schema:CreativeWork
168 https://doi.org/10.1016/s0140-6736(03)13306-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050414744
169 rdf:type schema:CreativeWork
170 https://doi.org/10.1016/s0278-5846(01)00279-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001219320
171 rdf:type schema:CreativeWork
172 https://doi.org/10.1016/s0750-7658(98)80017-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1012456994
173 rdf:type schema:CreativeWork
174 https://doi.org/10.1016/s0920-9964(01)00309-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001155253
175 rdf:type schema:CreativeWork
176 https://doi.org/10.1016/s0924-9338(00)00222-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1040498665
177 rdf:type schema:CreativeWork
178 https://doi.org/10.1016/s0924-977x(02)00031-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048794082
179 rdf:type schema:CreativeWork
180 https://doi.org/10.1034/j.1399-5618.2000.020307.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1049226594
181 rdf:type schema:CreativeWork
182 https://doi.org/10.1034/j.1600-0447.2002.00242.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1032115125
183 rdf:type schema:CreativeWork
184 https://doi.org/10.1046/j.1365-2125.2000.00108.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1012089803
185 rdf:type schema:CreativeWork
186 https://doi.org/10.1093/oxfordjournals.schbul.a006928 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051418549
187 rdf:type schema:CreativeWork
188 https://doi.org/10.1111/j.1440-1819.1997.tb03204.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1024540211
189 rdf:type schema:CreativeWork
190 https://doi.org/10.1176/ajp.144.6.778 schema:sameAs https://app.dimensions.ai/details/publication/pub.1063477512
191 rdf:type schema:CreativeWork
192 https://doi.org/10.1176/ajp.148.6.714 schema:sameAs https://app.dimensions.ai/details/publication/pub.1063480714
193 rdf:type schema:CreativeWork
194 https://doi.org/10.1176/ajp.152.3.473-a schema:sameAs https://app.dimensions.ai/details/publication/pub.1063483712
195 rdf:type schema:CreativeWork
196 https://doi.org/10.1176/ajp.152.7.1038 schema:sameAs https://app.dimensions.ai/details/publication/pub.1063483905
197 rdf:type schema:CreativeWork
198 https://doi.org/10.1176/appi.ajp.159.6.1035 schema:sameAs https://app.dimensions.ai/details/publication/pub.1063494678
199 rdf:type schema:CreativeWork
200 https://doi.org/10.4088/jcp.v63n1211 schema:sameAs https://app.dimensions.ai/details/publication/pub.1072208337
201 rdf:type schema:CreativeWork
202 https://www.grid.ac/institutes/grid.411784.f schema:alternateName Hôpital Cochin
203 schema:name Inserm U669 PSIGIAM (Paris Sud Innovation Group In Adolescent Mental health Methodology), Cochin Hospital, 97 boulevard de Port Royal, 75679, Paris cedex 14, France
204 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...